Results 191 to 200 of about 49,053 (243)

Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir. [PDF]

Front Public Health
Perno CF, Orlando S, Majid NA, Sangare H, Luanga R, Roccucci M, Silaghi LA, Sidumo Z, Brambilla D, Ceffa S, Guidotti G, Ciccacci F.   +11 more
europepmc   +1 more source

In Vitro Pharmacokinetic Properties of MK-2048, a Potent Drug Candidate for HIV Prevention. [PDF]

Viruses
Zheng R, Valicherla GR, Graebing PW, Zhang J, Hillier SL, Rohan LC.   +5 more
europepmc   +1 more source

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity. [PDF]

Virol J
Washaya T, Chimukangara B, Mayini J, Bote S, Chin'ombe N, Munyati S, Manasa J.   +6 more
europepmc   +1 more source